Maria I Longo
Overview
Explore the profile of Maria I Longo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kreher M, Noland M, Konda S, Longo M, Valdes-Rodriguez R
J Am Acad Dermatol
. 2022 Dec;
88(3):521-530.
PMID: 36460257
Immunosuppression is a well-documented risk factor for skin cancer, as exemplified by the 65- to 250-fold higher squamous cell carcinoma risk, 10-fold higher basal cell carcinoma risk, and 0 to...
2.
Kreher M, Konda S, Noland M, Longo M, Valdes-Rodriguez R
J Am Acad Dermatol
. 2022 Dec;
88(3):534-542.
PMID: 36460256
In solid organ transplant recipients, skin cancer risk associated with posttransplant immunosuppression has been well-described, and screening practices generally reflect these risks. In addition to agents used posttransplant, other classes...
3.
Wells A, Monir R, Bender N, Longo M, Vincek V
Dermatol Online J
. 2021 Apr;
27(3).
PMID: 33865281
Reactive angioendotheliomatosis (RAE) is an uncommon, benign, antiproliferative condition associated with systemic diseases that may cause occlusion or inflammation of the vascular lumina. A link between antiphospholipid syndrome (APS) and...
4.
Crow L, Jambusaria-Pahlajani A, Chung C, Baran D, Lowenstein S, Abdelmalek M, et al.
Transpl Int
. 2019 Sep;
32(12):1268-1276.
PMID: 31502728
Skin cancer is the most common malignancy affecting solid organ transplant recipients (SOTR), and SOTR experience increased skin cancer-associated morbidity and mortality. There are no formal multidisciplinary guidelines for skin...
5.
Herold M, Good A, Nielson C, Longo M
Dermatol Surg
. 2019 Aug;
45(12):1442-1449.
PMID: 31403546
Background: Solid organ transplant recipients (SOTRs) are at an increased risk of epithelial malignancies, mainly squamous cell carcinoma, and its precursor lesions such as actinic keratoses, warts, and porokeratosis, which...
6.
Nielson C, Potter K, Longo M
Int J Dermatol
. 2019 Jul;
59(1):e5-e6.
PMID: 31353449
No abstract available.
7.
Herold M, Nielson C, Longo M
Dermatol Ther
. 2018 Dec;
32(2):e12803.
PMID: 30536495
Treatment of recalcitrant warts in solid organ transplant recipients (SOTR) can pose a therapeutic challenge for dermatologists. Successful treatment of recalcitrant warts can serve as secondary prevention for skin cancer...
8.
Gillihan R, Merritt J, Beers P, Longo M
Int J Dermatol
. 2018 Nov;
58(5):605-606.
PMID: 30414189
No abstract available.
9.
Wozniak M, Villuendas R, Bischoff J, Aparicio C, Martinez Leal J, de la Cueva P, et al.
Haematologica
. 2010 Feb;
95(4):613-21.
PMID: 20133897
Background: Vorinostat (suberoylanilide hydroxamic acid, SAHA), an inhibitor of class I and II histone deacetylases, has been approved for the treatment of cutaneous T-cell lymphoma. In spite of emerging information...